A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OC / octreotide

[Related PubMed/MEDLINE]
Total Number of Papers: 16
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OC  (>> Co-occurring Abbreviation)
Long Form:   octreotide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2015 The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma. AFP, DENA, HCC, i.p, LIE, MDA, SSTR2
2011 Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. GIP, GLP-1, PDX-1, RYGB, STM
2009 Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache. ---
2007 Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. microPET, sst, TETA
2007 Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. CSs, HB
2003 Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? AT, PT
2002 Effects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding. HAPI, PN, SS
2002 The effect of octreotide on kainate-induced wet dog shakes and seizure activity in male and female rats. KA, NO, SS, WDS
2001 [Comparison between integrated 24-hour concentrations of growth hormone, insulin-like growth factor I and prolactin in acromegalic patients treated with octreotide and patients treated with octreotide LAR]. OC-LAR, PRL
10  1999 A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly. ---
11  1999 Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. TETA
12  1999 In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake. PET, TETA-Y3-TATE
13  1998 Scintigraphic imaging of pituitary adenomas: an in vivo evaluation of somatostatin receptors. AR, NFA, SS, SSR
14  1998 The effect of low dose octreotide administration on renal function and on gene expression of IGF-I axis components in experimental diabetes mellitus. DM, IGF-IR, IGFBP-1
15  1995 The effect of octreotid on bacterial translocation from the gut. An experimental study. ST
16  1993 Octreotide treatment does not affect the size of most non-functioning pituitary adenomas. CT